Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Achieved up to 24% body weight loss in clinical trials for obesity
Ultimately, they discovered the drug was able to reduce the risk for cardiovascular events by about 20% specifically in adults who are 45 and older, considered overweight or obese, not diabetic, and who have previously had a cardiovascular event
Adequate protein and micronutrient intake supports energy maintenance
KEEP REFRIGERATED Over 90% absorption rate
IGF-1 acts at both the hypothalamus (stimulating somatostatin) and directly at the pituitary (inhibiting somatotroph responsiveness)
US$ 24.97
US$ 26.82
US$ 22.51
US$ 22.31
US$ 23.40
US$ 23.64
